Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Sunshine Biopharma, Inc. (SBFM) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$9.42M |
|
$-0.88M |
|
$6.34M |
|
$3.07M |
|
$10.50M |
|
$-1.09M |
|
$0.07M |
|
$-1.02M |
|
$-1.02M |
|
$-0.88M |
|
$-0.88M |
|
$-0.88M |
|
$-0.88M |
|
$-1.09M |
|
$-0.44M |
|
4.56M |
|
4.56M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$27.97M |
|
$0.60M |
|
$3.52M |
|
$31.49M |
|
$6.65M |
|
-- |
|
$0.64M |
|
$7.29M |
|
$24.19M |
|
$22.19M |
|
$24.20M |
|
4.56M |
|
| Cash Flow Statement Financials | |
$-3.72M |
|
$-0.79M |
|
$4.02M |
|
$9.69M |
|
$9.31M |
|
$-0.38M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
32.64% |
|
-11.54% |
|
-11.54% |
|
-- |
|
-10.84% |
|
-9.39% |
|
$-3.88M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.45 |
|
2.27 |
|
39.72 |
|
-3.65% |
|
-3.98% |
|
-2.81% |
|
-3.65% |
|
$5.31 |
|
$-0.85 |
|
$-0.82 |
|